Presentations we supply
- Injection 0.5 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for RanibizumabReference information
Summarised from the product information for Lucentis. Always follow the product information approved in your own country.
- Active substance
- Ranibizumab
- Pharmacotherapeutic group
- Ophthalmologicals, antineovascularisation agents (ATC code S01LA04)
- Authorised uses
- Neovascular (wet) age-related macular degeneration in adults
- Visual impairment due to diabetic macular oedema in adults
- Proliferative diabetic retinopathy in adults
- Visual impairment due to macular oedema secondary to retinal vein occlusion in adults
- Visual impairment due to choroidal neovascularisation in adults
- Retinopathy of prematurity in preterm infants
- Storage (unopened)
- Store in a refrigerator (2 °C to 8 °C). Do not freeze. Keep the vial in the outer carton in order to protect from light. Before use, the unopened vial may be kept at room temperature (25 °C) for up to 24 hours.
- Shelf life (unopened)
- 3 years
- Container and pack
- Type I glass vial with chlorobutyl rubber stopper, 0.23 ml; pack of 1 vial, or 1 vial with a filter needle
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Cold-chain shipment for this refrigerated product.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Lucentis: www.ema.europa.eu